Manhattan Bridge Capital, Inc
LOAN Nasdaq Real Estate Investment Trusts Financials FY2016βFY2025
What Manhattan Bridge Capital, Inc does
No business description yet.
- Legal name
- MANHATTAN BRIDGE CAPITAL, INC
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 27, 2026
- Accession Β· CIK
- 0001493152-26-013241
0001080340
Revenue and margins
Manhattan Bridge Capital, Inc had $8.7M of revenue in fiscal 2025, down 10.6% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 2.2% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $4.9M in fiscal 2025, 56.9% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Manhattan Bridge Capital, Inc returned $5.3M to shareholders in fiscal 2025, 107% of free cash flow. The diluted share count fell 0.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Manhattan Bridge Capital, Inc can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $0.1M | $0.1M | $0.1M | $0.2M | $0.2M |
| Debt incl. finance leases | β | β | β | $7.2M | $6.2M |
| Net debt / EBITDA | β | β | β | 1.3x | 1.2x |
| Debt / equity | β | β | β | 0.2x | 0.1x |
| Interest coverage | β | β | 2.2x | 2.5x | 3.1x |
| Total assets | $67.2M | $76.3M | $76.4M | $67.4M | $62.4M |
| Total liabilities | $23.8M | $33.4M | $33.5M | $24.1M | $19.3M |
| Shareholders' equity | $43.4M | $42.9M | $42.9M | $43.3M | $43.1M |
| Net debt (β = net cash) | β | β | β | $7.0M | $6.0M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 | 4 / 7 |
| Accruals ratio | β0.6% | β0.1% | β0.3% | 0.1% | 0.0% | β0.3% | 0.1% | 0.1% | 0.9% | 0.3% |
| Altman Z'' | 6.06 | β | β | β | β | β | β | β | β | β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $4.6M | $5.9M | $7.2M | $7.3M | $7.0M | $6.8M | $8.6M | $9.8M | $9.7M | $8.7M |
| Operating income | $2.9M | $3.5M | $4.2M | $4.5M | $4.2M | $4.4M | $5.2M | $5.4M | $5.6M | $5.1M |
| Interest expense | β | β | β | β | β | β | β | $2.4M | $2.2M | $1.6M |
| Pretax income | $2.8M | $3.4M | $4.2M | $4.5M | $4.2M | $4.4M | $5.2M | $5.5M | $5.6M | $5.1M |
| Income tax | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Net income | $2.8M | $3.4M | $4.2M | $4.5M | $4.2M | $4.4M | $5.2M | $5.5M | $5.6M | $5.1M |
| Diluted EPS | $0.37 | $0.42 | $0.48 | $0.47 | $0.44 | $0.42 | $0.45 | $0.48 | $0.49 | $0.45 |
| Diluted shares | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B |
| Cash flow | ||||||||||
| Cash from operations | $3.1M | $3.5M | $4.4M | $4.4M | $4.2M | $4.6M | $5.2M | $5.4M | $4.9M | $4.9M |
| Capital expenditure | $0.0M | $0.0M | $0.0M | β | $0.0M | β | $0.0M | $0.0M | $0.0M | $0.0M |
| Free cash flow | $3.0M | $3.5M | $4.4M | β | $4.2M | β | $5.2M | $5.4M | $4.9M | $4.9M |
| Depreciation and amortization | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Stock-based compensation | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends paid | $2.7M | $3.3M | $4.0M | $4.6M | $4.1M | $5.0M | $5.7M | $5.3M | $5.2M | $5.3M |
| Dividends and buybacks | $2.7M | $3.3M | $4.0M | $4.6M | $4.1M | $5.0M | $5.7M | $5.3M | $5.2M | $5.3M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $0.1M | $0.1M | $0.2M | $0.1M | $0.1M | $0.1M | $0.1M | $0.1M | $0.2M | $0.2M |
| Total debt | β | β | β | β | β | β | β | β | $7.2M | $6.2M |
| Loans, net | β | β | β | β | $43.7M | $49.3M | $60.9M | β | β | β |
| Current assets | $28.0M | β | β | β | β | β | β | β | β | β |
| Current liabilities | $7.7M | β | β | β | β | β | β | β | β | β |
| Property and equipment, net | $0.0M | β | β | β | β | β | β | β | β | β |
| Total assets | $35.3M | $45.9M | $55.9M | $54.4M | $59.8M | $67.2M | $76.3M | $76.4M | $67.4M | $62.4M |
| Total liabilities | $13.0M | $23.7M | $23.8M | $22.5M | $27.9M | $23.8M | $33.4M | $33.5M | $24.1M | $19.3M |
| Shareholders' equity | $22.3M | $22.2M | $32.1M | $31.9M | $32.0M | $43.4M | $42.9M | $42.9M | $43.3M | $43.1M |
| Margins | ||||||||||
| Operating margin | 61.4% | 58.5% | 58.2% | 61.3% | 60.1% | 64.7% | 60.6% | 55.6% | 57.5% | 58.8% |
| EBITDA margin | 61.5% | 58.6% | 58.2% | 61.3% | 60.1% | 64.8% | 60.6% | 55.6% | 57.6% | 58.8% |
| Net margin | 61.0% | 58.1% | 58.2% | 61.2% | 60.4% | 65.0% | 60.8% | 55.9% | 57.7% | 59.0% |
| FCF margin | 65.6% | 58.5% | 60.3% | β | 60.1% | β | 60.3% | 55.0% | 50.9% | 56.9% |
| Returns | ||||||||||
| Return on capital | β | β | β | β | β | β | β | β | 11.1% | 10.4% |
| Return on capital employed | 10.3% | β | β | β | β | β | β | β | β | β |
| Return on equity | 12.7% | 15.4% | 15.5% | 14.0% | 13.2% | 11.7% | 12.1% | 12.8% | 13.0% | 11.8% |
| Return on assets | 8.0% | 8.5% | 8.3% | 8.1% | 7.4% | 7.0% | 7.3% | 7.2% | 7.8% | 7.9% |
| Return on tangible equity | 12.7% | 15.5% | 13.1% | 14.1% | 13.2% | 10.2% | 12.2% | 12.8% | 12.9% | 11.9% |
| Growth | ||||||||||
| Revenue growth | β | 27.3% | 22.1% | 1.6% | β4.5% | β2.8% | 25.9% | 14.3% | β1.1% | β10.6% |
| Net income growth | β | 21.2% | 22.3% | 6.9% | β5.9% | 4.6% | 17.8% | 5.1% | 2.1% | β8.6% |
| EPS growth | β | 13.5% | 14.3% | β2.1% | β6.4% | β4.5% | 7.1% | 6.7% | 2.1% | β8.2% |
| FCF growth | β | 13.5% | 26.0% | β | β | β | β | 4.4% | β8.6% | 0.0% |
| Share count change | β | 6.8% | 8.2% | 9.8% | β0.3% | 9.3% | 9.2% | β0.2% | β0.3% | β0.0% |
| Financial health | ||||||||||
| Net debt / EBITDA | β | β | β | β | β | β | β | β | 1.3x | 1.2x |
| Debt / equity | β | β | β | β | β | β | β | β | 0.2x | 0.1x |
| Interest coverage | β | β | β | β | β | β | β | 2.2x | 2.5x | 3.1x |
| Current ratio | 3.6x | β | β | β | β | β | β | β | β | β |
| Quick ratio | 3.6x | β | β | β | β | β | β | β | β | β |
| Capital allocation | ||||||||||
| Capex / revenue | 0.1% | 0.0% | 0.0% | β | 0.1% | β | 0.0% | 0.1% | 0.0% | 0.0% |
| Stock comp / revenue | 0.3% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.1% | 0.1% | 0.2% |
| Payouts / FCF | 88.7% | 95.0% | 91.7% | β | 98.4% | β | 111.3% | 98.5% | 106.2% | 106.8% |
| Quality scores | ||||||||||
| Piotroski F-score | β | β | β | β | β | β | β | β | β | 4.0 |
| Altman Z'' | 6.1 | β | β | β | β | β | β | β | β | β |
| Accruals ratio | β0.6% | β0.1% | β0.3% | 0.1% | 0.0% | β0.3% | 0.1% | 0.1% | 0.9% | 0.3% |
Source: SEC EDGAR XBRL filings (CIK 0001080340). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.